A meta-analysis examining the association of FOXP3+ cells with survival across different tumor types has shown varying directions of effect [28], and additional findings of a favorable association have been shown by IHC in ER-negative breast cancer [29] and high-grade serous tubo-ovarian cancer [30]. Here, FOXP3 is linked to neoplasm.